Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors. - Darby RA; Unsworth A; Knapp S; Kerr ID; Callaghan R (Cancer chemotherapy and pharmacology, 2015)